Pilot Research Project Core NIDA "COE" Transcriptomics, Systems Genetics and the Addictome

NIH RePORTER · NIH · P30 · $27,758 · view on reporter.nih.gov ↗

Abstract

Addiction is a highly complex disease with risk factors that include genetic variants and differences in development, sex, and environment. The long term potential of precision medicine to improve drug treatment and prevention depends on gaining a much better understanding how genetics, drugs, brain cells, and neuronal circuitry interact to influence behavior. There are serious technical barriers that prevent researchers and clinicians from incorporating more powerful computational and predictive methods in addiction research. The purpose of the NIDA P30 Core Center of Excellence in Omics, Systems Genetics, and the Addictome is to empower and train researchers supported by NIH, NIDA, NIAAA, and other federal and state institutions to use more quantitative and testable ways to analyze genetic, epigenetic, and the environmental factors that influence drug abuse risk and treatment. Our Pilot core is catalyzing new collaborations among early career investigators in the field of addiction research. In sum the Center is a national resource for reproducible research in addiction. We are centralizing, archiving, distributing, analyzing and integrating high quality data, metadata, using open software systems in collaboration with many other teams of researchers. Our goal is to help build toward an NIDA Addictome Portal that will include all genomic research relevant to addiction research.

Key facts

NIH application ID
10177982
Project number
5P30DA044223-05
Recipient
UNIVERSITY OF TENNESSEE HEALTH SCI CTR
Principal Investigator
ROBERT W. WILLIAMS
Activity code
P30
Funding institute
NIH
Fiscal year
2021
Award amount
$27,758
Award type
5
Project period
2017-08-01 → 2024-05-31